GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It operates in Mainland China, Hong Kong, Vietnam, and Bangladesh. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

執行長

員工

國家

ISIN

US36151G1058

WKN

000A2QK2J

上市

0 Comments

分享你的想法

FAQ

GBS 今天的股價是多少？▼

GBS 目前價格為 $0.47 USD，過去 24 小時下跌了 -0.57%。在圖表上更密切關注 GBS 股票的表現。

GBS 的股票代號是什麼？▼

根據交易所不同，股票代號可能會有所差異。例如，在交易所，GBS 的股票以代號 GBS 進行交易。

GBS 去年的營收是多少？▼

GBS 去年的營收為 177.79USD。

GBS 去年的淨利是多少？▼

GBS 去年的淨收益為 -4.85MUSD。

GBS 有多少名員工？▼

截至 April 05, 2026，公司共有 7 名員工。

GBS 位於哪個產業？▼

GBS從事於Manufacturing產業。

GBS 何時完成拆股？▼

GBS 最近沒有進行任何拆股。

GBS 的總部在哪裡？▼

GBS 的總部位於 US 的 New York。